Abiopharma

🔍 BENNETT C FRANK (Executive)

Company: IONIS PHARMACEUTICALS INC (IONS)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 110 shares of Common Stock at $51.306 per share (Direct)
  Date: 2026-08-31 | Code: J | equity_swap_involved: 0 | shares_owned_after: 60,128.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Reporting shares purchased under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 31, 2026. These shares may not be sold until February 28, 2027.